| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMARIN CORP PLC | 350,000 | 536,000 | 0.01% | ||
| 2 | BIOMARIN PHARMACEUTICAL INC 0.75 10/15/2018 | 500,000 | 579,000 | 0.01% | PRN | |
| 3 | BIOMARIN PHARMACEUTICAL INC SR SB CONV NT 20 | 500,000 | 594,000 | 0.01% | PRN | |
| 4 | QLT INC | 500,000 | 995,000 | 0.01% | ||
| 5 | BIOLINERX LTD | 1,038,600 | 1,059,000 | 0.01% | ||
| 6 | COGENTIX MED INC | 990,745 | 1,090,000 | 0.01% | ||
| 7 | PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | 1,127,000 | 0.01% | ||
| 8 | FATE THERAPEUTICS INC | 692,900 | 1,247,000 | 0.01% | ||
| 9 | XTANT MED HLDGS INC | 475,439 | 1,288,000 | 0.01% | ||
| 10 | ACHILLION PHARMACEUTICALS IN | 200,000 | 1,544,000 | 0.02% | Call | |
| 11 | MEDIGUS LTD | 600,000 | 1,608,000 | 0.02% | ||
| 12 | PORTOLA PHARMACEUTICALS INC | 100,000 | 2,040,000 | 0.02% | Put | |
| 13 | OREXIGEN THERAPEUTICS INC | 5,210,000 | 2,149,000 | 0.02% | PRN | |
| 14 | UNIQURE NV | 184,800 | 2,195,000 | 0.02% | ||
| 15 | ROKA BIOSCIENCE INC | 3,220,429 | 2,222,000 | 0.02% | ||
| 16 | ALIMERA SCIENCES INC | 1,500,000 | 2,625,000 | 0.03% | ||
| 17 | Anacor Pharmaceuticals Inc | 53,300 | 2,849,000 | 0.03% | ||
| 18 | MYLAN N V | 69,800 | 3,235,000 | 0.03% | ||
| 19 | CERUS CORP | 578,300 | 3,429,000 | 0.04% | ||
| 20 | ADAPTIMMUNE THERAPEUTICS PLC | 438,784 | 3,567,000 | 0.04% | ||
| 21 | Ascendis Pharma | 222,223 | 4,122,000 | 0.04% | ||
| 22 | MIRATI THERAPEUTICS INC COM | 197,859 | 4,234,000 | 0.04% | ||
| 23 | SERES THERAPEUTICS INC | 166,645 | 4,426,000 | 0.05% | ||
| 24 | CONNECTURE INC | 1,740,000 | 4,454,000 | 0.05% | ||
| 25 | INVITAE CORP | 456,666 | 4,672,000 | 0.05% | ||
| 26 | VALEANT PHARMACEUTICALS INTL | 194,900 | 5,126,000 | 0.05% | ||
| 27 | Marinus Pharmaceuticals Inc | 965,000 | 5,192,000 | 0.05% | ||
| 28 | LION BIOTECHNOLOGIES INC COM | 1,022,100 | 5,192,000 | 0.05% | ||
| 29 | FLUIDIGM CORP DEL | 10,000,000 | 5,553,000 | 0.06% | PRN | |
| 30 | QIAGEN NV | 256,800 | 5,737,000 | 0.06% | ||
| 31 | ADVAXIS INC COM NEW | 636,600 | 5,748,000 | 0.06% | ||
| 32 | MACROGENICS INC | 317,000 | 5,944,000 | 0.06% | ||
| 33 | SYNERGY PHARMACEUTICALS DEL | 2,276,648 | 6,284,000 | 0.07% | ||
| 34 | INCYTE CORP SR CV NT0.375 18 | 4,250,000 | 6,574,000 | 0.07% | PRN | |
| 35 | INCYTE CORP | 4,250,000 | 6,727,000 | 0.07% | PRN | |
| 36 | REDHILL BIOPHARMA LTD | 564,900 | 6,920,000 | 0.07% | ||
| 37 | ASSEMBLY BIOSCIENCES INC | 1,397,100 | 7,013,000 | 0.07% | ||
| 38 | Biotie Therapies Corp. | 268,672 | 7,090,000 | 0.07% | ||
| 39 | ENANTA PHARMACEUTICALS INC | 249,400 | 7,325,000 | 0.08% | ||
| 40 | ULTRAGENYX PHARMACEUTICAL INC COM | 128,300 | 8,123,000 | 0.09% | ||
| 41 | INTRA-CELLULAR THERAPIES INC | 294,000 | 8,173,000 | 0.09% | ||
| 42 | AETNA INC NEW | 76,000 | 8,539,000 | 0.09% | ||
| 43 | SIENTRA INC | 1,357,500 | 9,285,000 | 0.10% | ||
| 44 | IMMUNOMEDICS INCORPORATED | 3,802,000 | 9,505,000 | 0.10% | ||
| 45 | GALAPAGOS NV | 230,000 | 9,619,000 | 0.10% | ||
| 46 | CELLECTIS S A | 350,000 | 9,625,000 | 0.10% | ||
| 47 | ABBOTT LABS | 237,000 | 9,914,000 | 0.10% | ||
| 48 | Syndax Pharmaceuticals Inc | 757,365 | 10,088,000 | 0.11% | ||
| 49 | EDWARDS LIFESCIENCES CORP | 115,000 | 10,144,000 | 0.11% | ||
| 50 | INOTEK PHARMACEUTICALS CORP | 1,391,000 | 10,293,000 | 0.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003439, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
